Biomet Company Profile Most Recently Published by MarketPublishers.com

03 Nov 2011 • by Natalie Aster
Biomet Company Profile Most Recently Published by MarketPublishers.com

LONDON – Located in Warsaw, Indiana, Biomet Inc. is one of the five largest orthopedic implant manufacturers in the world, with distribution in the U.S., Europe, Asia and a wide range of emerging markets. Throughout its history, the company has also expanded into areas such as sports medicine and dental medical devices. As of 2011, Biomet distributed products in around 90 countries from pole to pole, gaining revenues in the billions.

New research report “Biomet Profile (Biomaterials, Large Joints, Small Joints, Spine & Trauma, Dental): Global Market Share Analysis by Region, SWOT, Product Pipeline & Financials 2012” developed by iData Research has been recently published by Market Publishers Ltd.

Report Details:

Title: Biomet Profile (Biomaterials, Large Joints, Small Joints, Spine & Trauma, Dental): Global Market Share Analysis by Region, SWOT, Product Pipeline & Financials 2012
Published: October, 2011
Pages: 202
Price: US$ 6,995

The report provides true insights into Biomet's business activities, covering the following information:

  • overview of the company history and current product divisions;
  • summary of corporate financials;
  • review of recently approved products and the results of preliminary clinical trials;
  • in-depth SWOT analysis of the company's orthopedic biomaterials divisions;
  • detailed look at the market share and performance of each division in various countries across the U.S., Europe and Asia; examination of market share and division revenues by individual country for each region of the globe (whenever possible).

Report Contents:

EXECUTIVE SUMMARY
1.1 BIOMET OVERVIEW
1.2 CORPORATE REVENUE GROWTH BY BUSINESS UNIT
1.3 GLOBAL REVENUE BY REGION
1.4 GLOBAL MARKET SHARE BY MARKET SIZE
1.5 MARKET SHARE: DENTAL IMPLANTS AND FINAL ABUTMENTS
1.6 MARKET SHARE: DENTAL BONE GRAFT SUBSTITUTES

RESEARCH METHODOLOGY
2.1 IDATA’S 9-STEP METHODOLOGY
  2.1.1 Step 1: Project Initiation & Team Selection
  2.1.2 Step 2: Prepare Data Systems and Perform Secondary Research
  2.1.3 Step 3: Preparation for Interviews & Questionnaire Design
  2.1.4 Step 4: Performing Primary Research
  2.1.5 Step 5: Research Analysis: Establishing Baseline Estimates
  2.1.6 Step 6: Market Forecast and Analysis
  2.1.7 Step 7: Identify Strategic Opportunities
  2.1.8 Step 8: Final Review and Market Release
  2.1.9 Step 9: Customer Feedback and Market Monitoring

BIOMET COMPANY OVERVIEW
3.1 INTRODUCTION
3.2 COMPANY PROFILE
  3.2.1 Business Units
    3.2.1.1 Orthopedic Reconstruction
    3.2.1.2 Orthopedic Trauma, Spine and Biologics
    3.2.1.3 Sports Medicine
    3.2.1.4 Craniomaxillofacial
    3.2.1.5 Dental
3.3 GLOBAL REVENUES
  3.3.1 Global Revenues by Division
  3.3.2 Global Revenues by Geography
3.4 COMPANY HISTORY
3.5 COMPANY INFORMATION
  3.5.1 Size
  3.5.2 Office and Facility Locations

FINANCIAL METRICS
4.1 INCOME STATEMENT
4.2 BALANCE SHEET
  4.2.1 Balance Sheet
  4.2.2 Company Debt

ORTHOPEDIC BIOMATERIALS PRODUCT PIPELINE
5.1 ORTHOPEDIC BIOMATERIALS
  5.1.1 U.S. FDA Investigational Device Exemption (IDE)
    5.1.1.1 Platelet Rich Plasmas for Tennis Elbow
  5.1.2 U.S. FDA Phase 1 Trials
    5.1.2.1 Bone Marrow Aspirate Concentration for Critical Limb Ischemia
  5.1.3 U.S. FDA 510(k) Submissions
    5.1.3.1 Bone Marrow Concentration System
  5.1.4 European CE Mark Trials
    5.1.4.1 ChonDux Trail Suspension
    5.1.4.2 Fat Concentration System

ORTHOPEDIC BIOMATERIALS SWOT ANALYSIS
6.1 ORTHOPEDIC BIOMATERIALS SWOT ANALYSIS
  6.1.1 Strengths
    6.1.1.1 Joint Reconstruction
    6.1.1.2 History in Orthopedic Biologics
    6.1.1.3 Market Leader in Cell Concentration Systems
    6.1.1.4 Restructured Management
  6.1.2 Weaknesses
    6.1.2.1 Competition from Larger Competitors
    6.1.2.2 Lack of Advanced Bone Graft Substitute Product
    6.1.2.3 Partial Reliance on Distributors in the United States
    6.1.2.4 High Debt Levels
    6.1.2.5 Spine and Trauma Fixation Divisions
    6.1.2.6 Staff Restructuring
  6.1.3 Opportunities
    6.1.3.1 Undeveloped Asian and Emerging Markets Presence
    6.1.3.2 Underdeveloped Hyaluronic Acid Viscosupplementation Potential
    6.1.3.3 Migration to Chinese Manufacturing
  6.1.4 Threats
    6.1.4.1 Cost Control
    6.1.4.2 Medical Conservatism
    6.1.4.3 Department of Justice Sanction
    6.1.4.4 European Sovereign Debt Crisis of 2010 and Onward
    6.1.4.5 Potential for Acquisition

ORTHOPEDIC BIOMATERIALS MARKET SHARE
7.1 MARKET INTRODUCTION
  7.1.1 Bone Graft Substitutes
    7.1.1.1 Introduction
    7.1.1.2 Indications
    7.1.1.3 Materials
  7.1.2 Cell Concentration
    7.1.2.1 Introduction
    7.1.2.2 Platelet Rich Plasma
    7.1.2.3 Bone Marrow Aspirate
  7.1.3 Hyaluronic Acid Viscosupplementation
    7.1.3.1 Introduction
    7.1.3.2 Benefits of Viscosupplementation
    7.1.3.3 Synovial Fluid
    7.1.3.4 Three-Injection Cycle Products
    7.1.3.5 Five-Injection Cycle Products
    7.1.3.6 Single-Injection Cycle Products
7.2 KEY PRODUCTS
  7.2.1 Bone Graft Substitutes
    7.2.1.1 Allograft / DBM
    7.2.1.2 Synthetic Bone Void Fillers
  7.2.2 Hyaluronic Acid Viscosupplementation
  7.2.3 Cell Concentration
7.3 MARKET SHARE AND REVENUE ANALYSIS
  7.3.1 Bone Graft Substitutes
    7.3.1.1 Global Market Share
    7.3.1.2 United States Market Share
    7.3.1.3 European Market Share by Country
    7.3.1.4 International Market Share
  7.3.2 Cell Concentration (Platelet and Bone Marrow)
    7.3.2.1 Global
    7.3.2.2 U.S. Market Share
    7.3.2.3 European and International Market Share
  7.3.3 Hyaluronic Acid Viscosupplementation
    7.3.3.1 Global
    7.3.3.2 U.S. Market Share
    7.3.3.3 European Market Share
    7.3.3.4 International Market Share

DENTAL PRODUCT PIPELINE
8.1 DENTAL IMPLANTS AND BONE GRAFT SUBSTITUTES
  8.1.1 U.S. FDA 510(k) Submissions

DENTAL SWOT ANALYSIS
9.1 DENTAL IMPLANTS, FINAL ABUTMENTS AND DENTAL BONE GRAFT SUBSTITUTES
  9.1.1 Strengths
  9.1.2 Weaknesses
  9.1.3 Opportunities
  9.1.4 Threats

DENTAL IMPLANTS MARKET SHARE
10.1 MARKET INTRODUCTION
  10.1.1 Dental Implants
    10.1.1.1 Root-Form Dental Implants
    10.1.1.2 Non Root-Form Implants
    10.1.1.3 Dental Implant Applications
    10.1.1.4 Mini-Implants
    10.1.1.5 Dental Implant Procedures
    10.1.1.6 Dental Implant Instrument Kits
  10.1.2 Introduction to Final Abutments
    10.1.2.1 Stock Abutments
    10.1.2.2 Custom Abutments
    10.1.2.3 CAD/CAM Abutments
10.2 MARKET SHARE AND REVENUE ANALYSIS
  10.2.1 Dental Implants and Final Abutments
    10.2.1.1 United States Market Share
    10.2.1.2 European Market Share
    10.2.1.3 Asia Pacific Market Share
    10.2.1.4 Chinese Market Share
    10.2.1.5 Latin American Market Share

DENTAL BONE GRAFT SUBSTITUTES, MEMBRANES AND TISSUE

ENGINEERING MARKET SHARE
11.1MARKET INTRODUCTION
  11.1.1 Applications of Dental Bone Graft Substitutes
    11.1.1.1 Dental Implant Procedures
    11.1.1.2 Periodontal Procedures
  11.1.2 Types of Dental Bone Graft Substitutes
    11.1.2.1 Autografts
    11.1.2.2 Allografts
    11.1.2.3 De-Mineralized Bone Matrix (DBM) Allografts
    11.1.2.4 Xenografts
    11.1.2.5 Synthetics
  11.1.3 Dental Membranes
11.2 MARKET SHARE AND REVENUE ANALYSIS
  11.2.1 Dental Bone Graft Substitutes
    11.2.1.1 Global Market Share
    11.2.1.2 U.S. Market Share
    11.2.1.3 European Market Share
      11.2.1.3.1 Dental Bone Graft Substitute Market Share by Country
      11.2.1.3.2 Dental Membrane Market Share by Country
    11.2.1.4 Asia Pacific Market Share

ORTHOPEDIC LARGE JOINT PRODUCT PIPELINE
11.3 LARGE JOINT RECONSTRUCTION
  11.3.1 U.S. FDA Investigational Device Exemption (IDE)
  11.3.2 U.S. FDA Trials
  11.3.3 International Trials
    11.3.3.1 Oxford Partial Knee using Signature Custom Guides and Conventional
Instrumentation
  11.3.4 U.S. FDA 510(k) Approvals
    11.3.4.1 Active Articulation E1
    11.3.4.2 Signature™ Personalized Patient Care System
    11.3.4.3 Vanguard™ Knee Prosthesis
    11.3.4.4 Taperloc™ Hip Replacement
  11.3.5 U.S. FDA PMA Approval Updates
    11.3.5.1 Oxford™ Partial Knee

ORTHOPEDIC LARGE JOINT SWOT ANALYSIS
12.1 LARGE JOINT RECONSTRUCTION SWOT ANALYSIS
  12.1.1 Strengths
  12.1.2 Weaknesses
  12.1.3 Opportunities
  12.1.4 Threats
    12.1.4.1 Troubled Global Economy

LARGE JOINT RECONSTRUCTION MARKET SHARE ANALYSIS
13.1 MARKET INTRODUCTION
  13.1.1 Knee Reconstruction
    13.1.1.1 Anatomy
    13.1.1.2 Pathology
    13.1.1.3 Implant Types
      13.1.1.3.1 Total Knee Replacement
      13.1.1.3.2 Partial Knee Replacement
      13.1.1.3.3 Patellofemoral Replacement
      13.1.1.3.4 Interpositional Knee Implants
      13.1.1.3.5 Knee Revision
    13.1.1.4 Fixation Method
    13.1.1.5 Bearing Surface
    13.1.1.6 Fixed verses Mobile Bearings
  13.1.2 Hip Reconstruction
    13.1.2.1 Anatomy
    13.1.2.2 Pathology
    13.1.2.3 Treatment
    13.1.2.4 Implant Types
      13.1.2.4.1 Total Hip Joint Replacement
      13.1.2.4.2 Partial Hip Joint Replacement
      13.1.2.4.3 Resurfacing Hip Joint Replacement
      13.1.2.4.4 Revision Hip Joint Replacement
    13.1.2.5 Fixation Method
    13.1.2.6 Implant Material
    13.1.2.7 Bearing Surface Technology
      13.1.2.7.1 Polyethylene Bearings
      13.1.2.7.2 Highly Cross-Linked Polyethylene Bearings
      13.1.2.7.3 Metal Bearings
      13.1.2.7.4 Ceramic Bearings
13.2 MARKET SHARE AND REVENUE ANALYSIS
  13.2.1 Combined Large Joint Reconstruction
    13.2.1.1 Global Market Share
    13.2.1.2 U.S. Market Share
    13.2.1.3 European Market Share by Country
    13.2.1.4 Asian Market Share by Country
  13.2.2 Hip Reconstruction
    13.2.2.1 Global Market Share
    13.2.2.2 Asia Pacific Market Share
  13.2.3 Knee Reconstruction
    13.2.3.1 Global
    13.2.3.2 Asia Pacific Market Share

SMALL JOINT RESONSTRUCTION PRODUCT PIPELINE
14.1 SMALL JOINT RECONSTRUCTION
  14.1.1 U.S. FDA 510(k) Approvals
    14.1.1.1 Bio-Modular™ Reverse Shoulder

SMALL JOINT RECONSTRUCTION SWOT ANALYSIS
15.1 SMALL JOINT RECONSTRUCTION SWOT ANALYSIS
  15.1.1 Strengths
  15.1.2 Weaknesses
  15.1.3 Opportunities
  15.1.4 Threats

SMALL JOINT RECONSTRUCTION MARKET SHARE
16.1 MARKET INTRODUCTION
  16.1.1 Introduction
  16.1.2 Anatomy and Pathology
    16.1.2.1 Osteoarthritis
    16.1.2.2 Inflammatory Arthritis
  16.1.3 Treatment
    16.1.3.1 Arthroplasty
    16.1.3.2 Ostectomy
    16.1.3.3 Internal Fixation
    16.1.3.4 External Fixation
  16.1.4 Treatment Devices
    16.1.4.1 Shoulder Joint Reconstruction Devices
    16.1.4.2 Elbow Joint Reconstruction
    16.1.4.3 Hand and Wrist Devices
    16.1.4.4 Foot and Ankle Devices
    16.1.4.5 Digit Replacement
    16.1.4.6 Cannulated Screws and Plate Fixation Devices
16.2 KEY PRODUCTS
  16.2.1 Shoulder Reconstruction
  16.2.2 Elbow Reconstruction
  16.2.3 Wrist Replacement
16.3 MARKET SHARE AND REVENUE ANALYSIS
  16.3.1 Small Joint Reconstruction
    16.3.1.1 Global Market Share
    16.3.1.2 United States Market Share
    16.3.1.3 European Market Share
      16.3.1.3.1 European Shoulder Reconstruction Market Share by Country
    16.3.1.4 Japanese Market Share

SPINAL IMPLANT AND ORTHOPEDIC TRAUMA PRODUCT PIPELINE
16.4 SPINAL IMPLANTS
  16.4.1 U.S. FDA 510(k) Submissions
    16.4.1.1 Polaris™ Spinal System, Intervertebral
    16.4.1.2 Polaris™ Spinal System, Pedicle
    16.4.1.3 Zyston™ Arc Interbody Spacer
16.5 ORTHOPEDIC TRAUMA
  16.5.1 U.S. FDA 510(k) Submissions
    16.5.1.1 Multi-Axial Correction (Mac) Male Adapter
    16.5.1.2 MaestroTM Wrist Plating System
    16.5.1.3 Explor® Radial Head Plating System
    16.5.1.4 ComprehensiveTM Proximal Humeral Plating System

SPIMAL IMPLANT AND ORTHPEDIC TRAUMA SWOT ANALYSIS
17.1 SPINAL IMPLANTS AND TRAUMA FIXATION SWOT ANALYSIS
  17.1.1 Strengths
  17.1.2 Weaknesses
  17.1.3 Opportunities
  17.1.4 Threats

SPINAL IMPLANTS MARKET SHARE
18.1 MARKET INTRODUCTION
  18.1.1 Introduction
    18.1.1.1 Spinal Fusion
    18.1.1.2 Traditional Interbody Fusion
      18.1.1.2.1 ALIF
      18.1.1.2.2 PLIF
      18.1.1.2.3 TLIF
      18.1.1.2.4 CIF
    18.1.1.3 Minimally Invasive Interbody Fusion
      18.1.1.3.1 Minimally Invasive TLIF (MITLIF)
      18.1.1.3.2 Minimally Invasive PLIF (MIPLIF)
      18.1.1.3.3 Lateral Lumbar Interbody Fusion (LLIF)
    18.1.1.4 Motion Preservation
      18.1.1.4.1 Artificial Discs
      18.1.1.4.2 Posterior Dynamic Stabilization
      18.1.1.4.3 Interspinous Process Decompression
      18.1.1.4.4 Nucleus Replacement
      18.1.1.4.5 Annular Repair
      18.1.1.4.6 Facet Arthroplasty
    18.1.1.5 Vertebral Compression Fracture (VCF)
    18.1.1.6 Electrical Stimulation
18.2 KEY PRODUCTS
  18.2.1 Cervical
  18.2.2 Thoracolumbar
  18.2.3 Spacers
  18.2.4 Vertebroplasty
18.3 MARKET SHARE AND REVENUE ANALYSIS
  18.3.1 Spinal Implants
    18.3.1.1 Global Market Share
    18.3.1.2 U.S. Market Share
    18.3.1.3 European Market Share
    18.3.1.4 Asia Pacific and Latin America

ORTHOPEDIC TRAUMA MARKET SHARE
19.1 MARKET INTRODUCTION
  19.1.1 Anatomy and Pathology
    19.1.1.1 Anatomy
    19.1.1.2 Pathology and Healing
  19.1.2 Treatment Overview
    19.1.2.1 Internal Fixation
    19.1.2.2 External Fixation
    19.1.2.3 Bone Growth Stimulation
  19.1.3 Internal Fixation
    19.1.3.1 Plates and Screws
    19.1.3.2 Bioabsorbable Plates and Screws
    19.1.3.3 Intramedullary Nails
    19.1.3.4 Cannulated Screws
    19.1.3.5 Conventional Hip Screws
    19.1.3.6 Intramedullary Hip Screws
    19.1.3.7 Pins, Wires and Cables
  19.1.4 External Fixation
  19.1.5 Long Bone Stimulators
19.2 KEY PRODUCTS
  19.2.1 Internal Plates and Screws
  19.2.2 Hip Fracture Screws
  19.2.3 Intramedullary Nails
  19.2.4 External Fixation
19.3 MARKET SHARE AND REVENUE ANALYSIS
  19.3.1 Trauma Fixation
    19.3.1.1 Global Market Share
    19.3.1.2 United States Market Share
    19.3.1.3 European Market Share
    19.3.1.4 Japanese Market Share

ABBREVIATIONS

LIST OF FIGURES

EXECUTIVE SUMMARY

RESEARCH METHODOLOGY

BIOMET COMPANY OVERVIEW
Figure 3-1: Global Revenues by Division, Biomet, (US$M), 2010 – 2011
Figure 3-2: Global Revenues Growth by Division, Biomet, 2011
Figure 3-3: Global Market Share and Revenue Growth by Market Size, Biomet (US$M), 2011
Figure 3-4: Global Revenues by Geography, Biomet, (US$M), 2010 – 2011
Figure 3-5: Company Size, Biomet, 2011
Figure 3-6: Key Facilities, Biomet, 2011

FINANCIAL METRICS
Figure 4-1: Income Statement, Biomet, 2009 – 2011 (US$M)
Figure 4-2: Balance Sheet, Biomet, 2009 – 2011 (US$M)
Figure 4-3: Company Debt, Biomet, 2011 (US$M)

ORTHOPEDIC BIOMATERIALS PRODUCT PIPELINE

ORTHOPEDIC BIOMATERIALS SWOT ANALYSIS

ORTHOPEDIC BIOMATERIALS MARKET SHARE
Figure 7-1: Bone Graft Substitutes Market Share, Biomet, 2011 (US$M)
Figure 7-2: Bone Graft Substitutes Market Share by Country, Europe, Biomet, 2011 (US$M)
Figure 7-3: Cell Concentration Market Share, Biomet, 2011
Figure 7-4: Hyaluronic Acid Viscosupplementation Market Share by Country, Biomet, 2011 (US$M)

DENTAL PRODUCT PIPELINE

DENTAL SWOT ANALYSIS

DENTAL IMPLANTS MARKET SHARE
Figure 7-1: Market Share, Biomet, 2011 (US$M)
Figure 7-2: Market Share by Country, Europe, Biomet, 2011 (US$M)
Figure 7-3: Market Share by Country, Asia Pacific, Biomet, 2011 (US$M)
Figure 7-4: Market Share by Country, Latin America, Biomet, 2011 (US$M)

DENTAL BONE GRAFT SUBSTITUTES, MEMBRANES AND TISSUE

ENGINEERING MARKET SHARE
Figure 8-1: Market Share, Biomet, 2011 (US$M)
Figure 8-2: Dental Bone Graft Substitute Market by Country, Europe, 2011 (US$M)
Figure 8-3: Dental Membrane Market by Country, Europe, 2011 (US$M)

ORTHOPEDIC LARGE JOINT PRODUCT PIPELINE

ORTHOPEDIC LARGE JOINT SWOT ANALYSIS

LARGE JOINT RECONSTRUCTION MARKET SHARE ANALYSIS
Figure 7-1: Large Joint Reconstruction Market Share, Biomet, 2011 (US$M)
Figure 7-2: Large Joint Reconstruction Market Share, Europe, Biomet, 2011 (US$M)
Figure 7-3: Large Joint Reconstruction Market Share, Asia, Biomet, 2011 (US$M)
Figure 7-4: Hip Reconstruction Market Share, Biomet, 2011 (US$M)
Figure 7-5: Hip Reconstruction Market Share by Country, Europe, Biomet, 2011 (US$M)
Figure 7-6: Hip Reconstruction Market Share by Country, Asia, Biomet, 2011 (US$M)
Figure 7-7: Knee Reconstruction Market Share, Biomet, 2011
Figure 7-8: Hip Reconstruction Market Share, Biomet, 2011
Figure 7-9: Knee Reconstruction Market Share, Biomet, 2011

SMALL JOINT RESONSTRUCTION PRODUCT PIPELINE

SMALL JOINT RECONSTRUCTION SWOT ANALYSIS

SMALL JOINT RECONSTRUCTION MARKET SHARE
Figure 7-1: Small Joint Reconstruction Market Share, Biomet, 2011 (US$M)
Figure 7-2: Shoulder Reconstruction Market Share, Europe, 2011 (US$M)

SPINAL IMPLANT AND ORTHOPEDIC TRAUMA PRODUCT PIPELINE

SPIMAL IMPLANT AND ORTHPEDIC TRAUMA SWOT ANALYSIS

SPINAL IMPLANTS MARKET SHARE
Figure 7-1: Spinal Implants Market Share, Biomet, 2011 (US$M)

ORTHOPEDIC TRAUMA MARKET SHARE
Figure 8-1: Orthopedic Trauma Market Share, Biomet, 2011 (US$M)

ABBREVIATIONS

LIST OF CHARTS

EXECUTIVE SUMMARY
Chart 1-1: Business Unit Revenue by Percentage, Biomet, 2011
Chart 1-2: Annual Revenue Growth by Business Unit, Biomet, 2011
Chart 1-3: Percentage of Global Revenues by Region, Biomet, 2011
Chart 1-4: Global Market Share and Revenue Growth by Market Size, Biomet (US$M), 2011
Chart 1-5: Global Dental Implants and Final Abutments Market Share, Biomet, 2011
Chart 1-6: Global Dental Bone Graft Substitutes Market Share, Biomet, 2011

RESEARCH METHODOLOGY

BIOMET COMPANY OVERVIEW
Chart 3-1: Global Revenues by Division, Biomet, 2011
Chart 3-2: Global Revenue Growth by Division, Biomet, 2011
Chart 3-3: Global Market Share and Revenue Growth by Market Size, Biomet (US$M), 2011
Chart 3-4: Global Revenues by Geography, Biomet, 2011
Chart 3-5: Countries with Key Administrative and Manufacturing Facilities, Biomet, 2011

FINANCIAL METRICS

ORTHOPEDIC BIOMATERIALS PRODUCT PIPELINE

ORTHOPEDIC BIOMATERIALS SWOT ANALYSIS

ORTHOPEDIC BIOMATERIALS MARKET SHARE
Chart 7-1: Global Bone Graft Substitutes Market Share, Biomet, 2011
Chart 7-2: Bone Graft Substitutes Market Share by Region, Biomet, 2011
Chart 7-3: Global Cell Concentration Market Share, Biomet, 2011
Chart 7-4: Cell Concentration Market Share by Region, Biomet, 2011
Chart 7-5: Global Hyaluronic Acid Viscosupplementation Market Share Biomet, 2011
Chart 7-6: Hyaluronic Acid Viscosupplementation Market Share by Country, Biomet, 2011

DENTAL PRODUCT PIPELINE

DENTAL SWOT ANALYSIS

DENTAL IMPLANTS MARKET SHARE
Chart 7-1: Global Dental Implant Market Share, Biomet, 2011
Chart 7-2: Dental Implant Market Share by Region, Biomet, 2011

DENTAL BONE GRAFT SUBSTITUTES, MEMBRANES AND TISSUE

ENGINEERING MARKET SHARE
Chart 8-1: Global Bone Graft Substitutes Market Share, Biomet, 2011
Chart 8-2: Bone Graft Substitutes Market Share by Region, Biomet, 2011

ORTHOPEDIC LARGE JOINT PRODUCT PIPELINE

ORTHOPEDIC LARGE JOINT SWOT ANALYSIS

LARGE JOINT RECONSTRUCTION MARKET SHARE ANALYSIS
Chart 7-1: Global Large Joint Reconstruction Market Share, Biomet, 2011 (US$M)
Chart 7-2: Large Joint Reconstruction Market Share by Region, Biomet, 2011 (US$M)
Chart 7-3: Global Hip Reconstruction Market Share, Biomet, 2011
Chart 7-4: Hip Reconstruction Market Share by Region, Biomet, 2011
Chart 7-5: Global Knee Reconstruction Market Share, Biomet, 2011

SMALL JOINT RESONSTRUCTION PRODUCT PIPELINE

SMALL JOINT RECONSTRUCTION SWOT ANALYSIS

SMALL JOINT RECONSTRUCTION MARKET SHARE
Chart 7-1: Global Small Joint Reconstruction Market Share, Biomet, 2011
Chart 7-2: Small Joint Reconstruction Market Share by Region, Biomet, 2011

SPINAL IMPLANT AND ORTHOPEDIC TRAUMA PRODUCT PIPELINE

SPIMAL IMPLANT AND ORTHPEDIC TRAUMA SWOT ANALYSIS

SPINAL IMPLANTS MARKET SHARE
Chart 7-1: Global Spinal Implants Market Share, Biomet, 2011
Chart 7-2: Spinal Implants Market Share by Region, Biomet, 2011

ORTHOPEDIC TRAUMA MARKET SHARE
Chart 8-1: Global Orthopedic Trauma Market Share, Biomet, 2011
Chart 8-2: Orthopedic Trauma Market Share by Region, Biomet, 2011

ABBREVIATIONS

More new reports by the publisher can be found at iData Research page.

 

CONTACTS

The Market Publishers, Ltd.

Tanya Rezler

Tel: +44 208 144 6009

Fax: +44 207 900 3970

ps@marketpublishers.com

www.marketpublishers.com